JENNIFER CRANDALL: Open Payments
NPI 1124776521 · WILSON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,070 in 134 payments from 21 companies in 2025. Trend: 2023 $1,924 · 2024 $2,065 · 2025 $2,070
Food & beverage: $2,070
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 44 | $425 |
| Janssen Pharmaceuticals, Inc | 9 | $224 |
| Neurocrine BioSciences, Inc. | 10 | $221 |
| Alkermes, Inc. | 11 | $193 |
| Axsome Therapeutics, Inc. | 11 | $173 |
| Otsuka America Pharmaceutical, Inc. | 11 | $171 |
| Almatica Pharma LLC | 9 | $140 |
| E.R. Squibb & Sons, L.L.C. | 4 | $88 |
| Vanda Pharmaceuticals Inc. | 4 | $69 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $62 |
Products named: VRAYLAR, INGREZZA, REXULTI, ARISTADA, SPRAVATO, LOREEV XR, Auvelity, COBENFY.
Industry payments across NC — which companies pay providers there.
